Achim Kautz is CEO of Kautz5 gUG – a non-profit project and consulting company for patient-centred care research and health concepts. He is actively advocating for liver patients since more than 20 years. Over these years he was CEO of the German patient organization “Deutsche Leberhilfe e.V.” and co-initiator of the European Liver Patients´ Association (ELPA) and the World Hepatitis Alliance (WHA). He has been part of a number of EU declarations and WHO resolutions mainly in the liver field and serves as a member of the consultancy group in the Ministry of Health in Germany looking after the national elimination strategy for HIV, viral hepatitis and STDs. He is the initiator of many metabolic disease-related health projects and active in NASH population research on national and international level. He is also co-initiator of the International Liver Cancer Movement (ILCM) with over 60 PAGs and scientific organizations globally. He is also a consultant for scientific associations and senior special advisor for Burson Cohn & Wolfe (BCW).
